rs406383
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000022.4(ADA):c.34-6463G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 152,010 control chromosomes in the GnomAD database, including 3,173 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.18 ( 3173 hom., cov: 32)
Consequence
ADA
NM_000022.4 intron
NM_000022.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.959
Publications
9 publications found
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
ADA Gene-Disease associations (from GenCC):
- severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health, Orphanet
- Omenn syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.278 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADA | NM_000022.4 | c.34-6463G>C | intron_variant | Intron 1 of 11 | ENST00000372874.9 | NP_000013.2 | ||
| ADA | NM_001322051.2 | c.34-6463G>C | intron_variant | Intron 1 of 10 | NP_001308980.1 | |||
| ADA | NM_001322050.2 | c.-256-6463G>C | intron_variant | Intron 1 of 10 | NP_001308979.1 | |||
| ADA | NR_136160.2 | n.126-6463G>C | intron_variant | Intron 1 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ADA | ENST00000372874.9 | c.34-6463G>C | intron_variant | Intron 1 of 11 | 1 | NM_000022.4 | ENSP00000361965.4 | |||
| ADA | ENST00000695995.1 | c.34-6463G>C | intron_variant | Intron 1 of 8 | ENSP00000512318.1 | |||||
| ADA | ENST00000695991.1 | c.34-6463G>C | intron_variant | Intron 1 of 7 | ENSP00000512314.1 | |||||
| ADA | ENST00000696038.1 | n.34-6463G>C | intron_variant | Intron 1 of 8 | ENSP00000512344.1 |
Frequencies
GnomAD3 genomes AF: 0.183 AC: 27735AN: 151892Hom.: 3172 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
27735
AN:
151892
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.182 AC: 27737AN: 152010Hom.: 3173 Cov.: 32 AF XY: 0.183 AC XY: 13581AN XY: 74282 show subpopulations
GnomAD4 genome
AF:
AC:
27737
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
13581
AN XY:
74282
show subpopulations
African (AFR)
AF:
AC:
2104
AN:
41508
American (AMR)
AF:
AC:
4356
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
469
AN:
3464
East Asian (EAS)
AF:
AC:
945
AN:
5154
South Asian (SAS)
AF:
AC:
981
AN:
4808
European-Finnish (FIN)
AF:
AC:
2290
AN:
10548
Middle Eastern (MID)
AF:
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15940
AN:
67952
Other (OTH)
AF:
AC:
403
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1122
2245
3367
4490
5612
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.